Monte Rosa Therapeutics I... (GLUE)
undefined
undefined%
At close: undefined
7.60
0.86%
After-hours Dec 13, 2024, 06:37 PM EST

Monte Rosa Therapeutics Inc. Forcast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for GLUE stock have an median target of 16, with a low estimate of 11 and a high estimate of 17. The median target predicts an increase of 112.20% from the current stock price of 7.54.

Analyst Consensus: Buy
Target Low Average Median High
Price $11 $14.67 $16 $17
Change 45.89% 94.56% 112.20% 125.46%

AI Analyst Report

Wedbush maintains an Outperform rating for Monte R... Unlock content with Pro Subscription

Updated Sep 12, 2024

Rating Feb 24May 24Jun 24Aug 24Sep 24
Strong Buy 00000
Buy 11111
Hold 00000
Sell 00000
Strong Sell 00000
Total 1 1 1 1 1

Financial Forecast this Year

Revenue This Year
11.52M
from 0
Increased by -%
Revenue Next Year
10.87M
from 11.52M
Increased by -5.7%
EPS This Year
-1.9
from -2.63
Increased by 27.8%
EPS Next Year
-1.93
from -1.9
Increased by -1.6%